Pan Yun Chu - Net Worth and Insider Trading

Pan Yun Chu Net Worth

The estimated net worth of Pan Yun Chu is at least $82,404 dollars as of 2025-07-22. Pan Yun Chu is the Director of Wanbangde Pharmaceutical Holding Group Co Ltd and owns about 10,800 shares of Wanbangde Pharmaceutical Holding Group Co Ltd (SZSE:002082) stock worth over $82,404. Details can be seen in Pan Yun Chu's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Pan Yun Chu has not made any transactions after 2016-09-26 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

Transaction Summary of Pan Yun Chu

Pan Yun Chu Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Pan Yun Chu owns 1 companies in total, including Wanbangde Pharmaceutical Holding Group Co Ltd (SZSE:002082) .

Click here to see the complete history of Pan Yun Chu’s form 4 insider trades.

Insider Ownership Summary of Pan Yun Chu

Ticker	Company	Transaction Date	Type of Owner
SZSE:002082	Wanbangde Pharmaceutical Holding Group Co Ltd	2016-09-26	Director

Pan Yun Chu Latest Holdings Summary

Pan Yun Chu currently owns a total of 1 stock. Pan Yun Chu owns 10,800 shares of Wanbangde Pharmaceutical Holding Group Co Ltd (SZSE:002082) as of September 26, 2016, with a value of $82,404.

Latest Holdings of Pan Yun Chu

Ticker	Company	Latest Transaction Date	Shares Owned	Current Price ($)	Current Value ($)
SZSE:002082	Wanbangde Pharmaceutical Holding Group Co Ltd	2016-09-26	10,800	7.63	82,404

Holding Weightings of Pan Yun Chu

Pan Yun Chu Form 4 Trading Tracker

According to the SEC Form 4 filings, Pan Yun Chu has made a total of 0 transactions in Wanbangde Pharmaceutical Holding Group Co Ltd (SZSE:002082) over the past 5 years. The most-recent trade in Wanbangde Pharmaceutical Holding Group Co Ltd is the sale of 3,600 shares on September 26, 2016, which brought Pan Yun Chu around $73,800.

Insider Trading History of Pan Yun Chu

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.

Total 0

Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Pan Yun Chu Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Pan Yun Chu Ownership Network

Ownership Network List of Pan Yun Chu

No Data

Ownership Network Relation of Pan Yun Chu

Pan Yun Chu Owned Company Details

What does Wanbangde Pharmaceutical Holding Group Co Ltd do?

Who are the key executives at Wanbangde Pharmaceutical Holding Group Co Ltd?

Pan Yun Chu is the Director of Wanbangde Pharmaceutical Holding Group Co Ltd. Other key executives at Wanbangde Pharmaceutical Holding Group Co Ltd include Directors & executives zhao shou ming , Supervisors Li Rong Fang , and Directors & executives Zhu Jian Xin .

Wanbangde Pharmaceutical Holding Group Co Ltd (SZSE:002082) Insider Trades Summary

Over the past 18 months, Pan Yun Chu made no insider transaction in Wanbangde Pharmaceutical Holding Group Co Ltd (SZSE:002082). Other recent insider transactions involving Wanbangde Pharmaceutical Holding Group Co Ltd (SZSE:002082) include a net purchase of 7,326,900 shares made by zhao shou ming ,

In summary, during the past 3 months, insiders sold 0 shares of Wanbangde Pharmaceutical Holding Group Co Ltd (SZSE:002082) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Wanbangde Pharmaceutical Holding Group Co Ltd (SZSE:002082) were sold and 7,326,900 shares were bought by its insiders, resulting in a net purchase of 7,326,900 shares.

Wanbangde Pharmaceutical Holding Group Co Ltd (SZSE:002082)'s detailed insider trading history can be found in Insider Trading Tracker table.

Wanbangde Pharmaceutical Holding Group Co Ltd Insider Transactions

No Available Data

Pan Yun Chu Mailing Address

Above is the net worth, insider trading, and ownership report for Pan Yun Chu. Currently GuruFocus does not have mailing address information for Pan Yun Chu.

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Instant Alerts Mobile App 中文

Education

Financial Glossary Tutorials FAQ Schedule Free Session Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us Advertise Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.